microRNA

Ivana Ruseska1, Amina Tucak-Smajić2, Ivan Vidaković3

  • 1Department of Pharmaceutical technology and Biopharmacy, Institute of Pharmaceutical Sciences, University of Graz, Universitätsplatz 1, 8010 Graz, Austria.

概括

microRNA-27a在治疗肥胖症方面表现有前途,但面临着交付挑战. 用人血清白蛋白 (HSA) 覆盖miRNA载的阴离子纳米结构脂质载体 (cNLC) 产生了albplex,增强了潜在的抗肥胖疗法的稳定性和细胞吸收.